Elevance Health (ELV) financial statements
+225.5%since 2007
- FY2025 revenue
- $199.1B▲ +12.5%
- FY2025 net income
- $5.7B▼ −5.3%
- FY2025 diluted EPS
- $25.21▼ −1.8%
- FY2025 free cash flow
- $3.2B▼ −30.3%
Elevance Health income statement
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Revenue | 199,125 | 177,011 | 171,340 |
| Operating income | 7,199 | 7,862 | 8,499 |
| Pretax income | 6,710 | 7,904 | 7,715 |
| Net income | 5,662 | 5,980 | 5,987 |
| Diluted earnings per share | 25.21 | 25.68 | 25.22 |
Elevance Health balance sheet
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Cash and cash equivalents | 9,491 | 8,288 | 6,526 |
| Total assets | 121,494 | 116,889 | 108,928 |
| Total liabilities | 77,468 | 75,463 | 69,523 |
| Total equity | 44,026 | 41,426 | 39,405 |
| Long-term debt | 30,797 | 29,218 | 23,246 |
Elevance Health cash flow statement
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Operating cash flow | 4,290 | 5,808 | 8,061 |
| Capital expenditure | -1,116 | -1,256 | -1,296 |
| Free cash flow (derived) | 3,174 | 4,552 | 6,765 |
| Dividends paid | -1,529 | -1,508 | -1,395 |
| Share repurchases | -2,605 | -2,900 | -2,676 |
Quarterly highlights
| USD millions | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 |
|---|---|---|---|---|
| Period ended | 30 Sep 2026 | 30 Jun 2026 | 31 Mar 2026 | 31 Dec 2025 |
| Revenue (derived) | 51,429 | 50,474 | 50,181 | 49,747 |
| Operating income (derived) | 1,269 | 1,763 | 2,086 | 309 |
| Net income (derived) | 1,365 | 1,454 | 1,760 | 547 |
| Diluted earnings per share | 6.27 | 6.71 | 8.00 | n/a |
| Operating cash flow (derived) | 1,267 | 1,913 | 4,332 | 84 |
| Total assets | 127,801 | 126,438 | 125,827 | 121,494 |
Elevance Health major shareholders
| Holder | Share of class | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | 7.8% | 17,694,658 | 17 April 2025 |
| Vanguard Capital Management | 7.1% | 16,601,224 | 30 April 2026 |
Elevance Health 10-K and SEC filings
| Filed | Form | Type | Description |
|---|---|---|---|
| 10 November 2026 | 8-K | Current report | Current report |
| 21 October 2026 | 10-Q | Quarterly report | Quarterly report |
| 21 October 2026 | 8-K | Current report | Current report |
| 10 September 2026 | 8-K | Current report | Current report |
| 15 July 2026 | 10-Q | Quarterly report | Quarterly report |
| 15 July 2026 | 8-K | Current report | Current report |
| 10 June 2026 | 8-K | Current report | Current report |
| 13 May 2026 | 8-K | Current report | Current report |
Common questions
What was Elevance Health's revenue in fiscal 2025?
Elevance Health reported $199.1 billion in revenue for fiscal 2025, the year ended 31 December 2025, up 12.5% from fiscal 2024.
What was Elevance Health's net income in fiscal 2025?
Elevance Health reported net income of $5.7 billion for fiscal 2025, the year ended 31 December 2025, down 5.3% from fiscal 2024. Diluted earnings per share were $25.21.
What was Elevance Health's free cash flow in fiscal 2025?
Elevance Health had $3.2 billion in free cash flow in fiscal 2025. Operating cash flow was $4.3 billion and capital expenditure was $1.1 billion.
What were Elevance Health's total assets at the end of fiscal 2025?
Elevance Health reported total assets of $121.5 billion at the end of fiscal 2025, the year ended 31 December 2025.
How much Elevance Health history do I get?
Every account gets the full history, annual and quarterly, with first reported values and as of dates.
Start with a free key
Free $10 credits every month, no card.Free $10 credits a month, no card.